|Articles|August 20, 2018
Syneos Health Acquires Kinapse
Advertisement
Syneos Health, Inc., a biopharmaceutical solutions organization, announced the acquisition of Kinapse, a market advisory and operational solutions provider, from Hg, a specialist investor based in the U.K in order to further enhance end-to-end capabilities.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Voyxact Lands FDA Accelerated Approval Following Positive Results in Phase III VISIONARY Trial
2
How the FDA’s CNPV Program Is Reshaping Trial Operations and Accelerated Review Strategies
3
2025 Veeva R&D and Quality Summit: Effectively Utilizing Clinical Reference Data
4
Novo Nordisk Submits Higher-Dose Wegovy Injectable for FDA Approval with Priority Voucher
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
